Occudo Quantitative Strategies LP Bausch Health Companies Inc. Transaction History

Occudo Quantitative Strategies LP

  • $501 Million
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
BUY
$7.06 - $23.63 $970,354 - $3.25 Million
137,444 Added 478.67%
166,158 $1.39 Million
Q1 2022

May 16, 2022
SELL
$21.6 - $27.79 $244,663 - $314,777
-11,327 Reduced 28.29%
28,714 $656,000
Q4 2021

Feb 14, 2022
BUY
$23.0 - $29.01 $920,943 - $1.16 Million
40,041 New
40,041 $1.11 Million
Q3 2021

Nov 15, 2021
SELL
$25.04 - $30.06 $541,064 - $649,536
-21,608 Closed
0 $0
Q2 2021

Aug 16, 2021
BUY
$27.43 - $32.7 $592,707 - $706,581
21,608 New
21,608 $634,000

Others Institutions Holding BHC

# of Institutions
254
Shares Held
253M
Call Options Held
5.53M
Put Options Held
16.5M
View Full List

About Bausch Health Companies Inc.

BHC Quotes by TradingView
  • Ticker BHC
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 361,728,000
  • Market Cap $2.67B
  • Description
  • Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...
More about BHC
Track This Portfolio

Track Occudo Quantitative Strategies LP Portfolio

Follow Occudo Quantitative Strategies LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Occudo Quantitative Strategies LP, based on Form 13F filings with the SEC.

News

Stay updated on Occudo Quantitative Strategies LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email